期刊
FUTURE MEDICINAL CHEMISTRY
卷 4, 期 18, 页码 2337-2360出版社
FUTURE SCI LTD
DOI: 10.4155/FMC.12.188
关键词
-
资金
- Medicines for Malaria venture Grant [MMV 12/2400]
- Bill and Melinda Gates Foundation Global Health Grant [OPP1040399]
- Bill and Melinda Gates Foundation [OPP1040399] Funding Source: Bill and Melinda Gates Foundation
The discovery of new chemical starting points with the ability to inhibit Plasmodium falciparum sexual stages, and therefore block the disease transmission, is urgently required. These will form the basis for the development of new therapeutic combinations for the treatment and elimination of malaria and the ultimate goal of global eradication. Recent screening of large chemical libraries against the parasite asexual stages has resulted in the public availability of focused subsets of known antimalarial actives, which represent an excellent starting point for the identification of new gametocytocidal compounds. New stage-specific methodologies aimed at increasing the throughput for assessing compound activity against in vitro cultured gametocytes have recently been published. This article discusses the challenges of assay-oriented large-scale gametocyte culturing and reviews the state-of-the art in gametocytocidal assay development and outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据